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OBJECTIVEdTo assess the predictive capacity of a recently described equation that we have
termed CUN-BAE (Clínica Universidad de Navarra-Body Adiposity Estimator) based on BMI,
sex, and age for estimating body fat percentage (BF%) and to study its clinical usefulness.
RESEARCH DESIGN ANDMETHODSdWe conducted a comparison study of the de-
veloped equation with many other anthropometric indices regarding its correlation with actual
BF% in a large cohort of 6,510 white subjects from both sexes (67% female) representing a wide
range of ages (18–80 years) and adiposity. Additionally, a validation study in a separate cohort
(n = 1,149) and a further analysis of the clinical usefulness of this prediction equation regarding
its association with cardiometabolic risk factors (n = 634) was carried out.
RESULTSdThe mean BF% in the cohort of 6,510 subjects determined by air displacement
plethysmography was 39.96 10.1%, and the mean BF% estimated by the CUN-BAEwas 39.36
8.9% (SE of the estimate, 4.66%). In this group, BF% calculated with the CUN-BAE showed the
highest correlation with actual BF% (r = 0.89, P , 0.000001) compared with other anthropo-
metric measures or BF% estimators. Similar agreement was found in the validation sample.
Moreover, BF% estimated by the CUN-BAE exhibits, in general, better correlations with cardi-
ometabolic risk factors than BMI as well as waist circumference in the subset of 634 subjects.
CONCLUSIONSdCUN-BAE is an easy-to-apply predictive equation that may be used as a
first screening tool in clinical practice. Furthermore, our equation may be a good tool for iden-
tifying patients at cardiovascular and type 2 diabetes risk.
Diabetes Care 35:383–388, 2012
The prevalence of obesity has increaseddramatically worldwide (1). Obesityis defined as a state of increased
adipose tissue of enough magnitude to
produce adverse health consequences being
associated with increased morbidity and
mortality (2). In this sense, excess adiposity
increases the risk, among other diseases, of
type 2 diabetes, cardiovascular disease,
fatty liver, sleep-breathing disorders,
and certain forms of cancer (1), reducing
life expectancy (2,3).
Although excess adiposity but not
excess body weight is the real culprit of
obesity-associated complications, the stud-
ies examining the effect of obesity-associated
health risks in which adiposity is actually
measured are less frequent than desired (4).
Body fat percentage (BF%) can be mea-
sured by different techniques, encompass-
ing skin-fold measurements to magnetic
resonance imaging (5). Other frequently
usedmethods for determining BF% include
bioelectrical impedance analysis (BIA) and
dual-energy X-ray absorptiometry (DEXA).
More accurate and reproducible methods
include underwater weighing and air dis-
placement plethysmography (ADP) (5–7).
When BF% determination is not
available, BMI is the most frequently
used surrogate measure of adiposity.
However, BMI, although easy to calculate,
exhibits notable inaccuracies not pre-
cisely reflecting body fat, changes in
body composition that take place in the
different periods of life or the sexual
dimorphism characteristics of body adi-
posity (8–11). Several prediction equa-
tions that account for sex and/or age in
converting weight and height to body fat
have been published and are reasonably
effective in overcoming the aforemen-
tioned problem, but they have been de-
rived from small samples or from imprecise
methods of measurement of body compo-
sition (10,12–14).
Because it is crucial to have available an
accurate estimator of BF%, not only to
better analyze the effect of adiposity on
obesity-associated cardiometabolic risk but
also to perform studies involving body
composition in which body fat may not
be actuallymeasured, the aimof the current
study was to assess the predictive capacity
of a recently described equation by our
group for estimating body adiposity and to
study its clinical usefulness. Therefore, we
conducted a comparison study of this
equation with many other anthropometric
indices in a large cohort of adults fromboth
sexes representing a wide range of ages and
adiposity, accompanied by a validation
study in a separate large cohort and a
further analysis of the clinical usefulness
of this prediction equation.
RESEARCH DESIGN AND
METHODS
Study design
We studied a sample of 6,510 white
subjects (2,154 men, 4,356 women),
aged 18–80 years, including patients vis-
iting our department. The study was per-
formed to evaluate the usefulness of a new
equation: BF%= –44.988+ (0.5033 age) +
(10.6893 sex) + (3.1723BMI)– (0.0263
BMI2) + (0.181 3 BMI 3 sex) – (0.02 3
BMI 3 age) – (0.005 3BMI2 3 sex) +
(0.00021 3 BMI2 3 age) where male =
0 and female = 1 for sex, and age in years,
developed by multiple regression to predict
BF% with a SE of the estimate (SEE) of
4.74% (15). Our equation, which may be
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used as an accurate body adiposity estima-
tor (BAE), was compared with common
extensively used anthropometric measure-
ments, including BMI,waist circumference,
waist-to-hip ratio, and waist-to-height, as
well as with other measurements less fre-
quently used to estimate adiposity such as
waist-to-height2, waist-to-height3, and
weight-to-height ratios, the Rohrer index,
and the recently described body adiposity
index (BAI) (16). To further validate the
predictability of the equation, we assessed
it in a separate cohort of 1,149 white sub-
jects (366 men, 783 women), aged 18–76
years, enrolled in another study for analyz-
ing the adiposity-associated type 2 diabetes
risk (17). Furthermore, we studied the as-
sociation of BF% with cardiometabolic risk
factors of 634 patients, comparing it with
BMI and waist circumference. Patients with
anorexia nervosa or bulimia nervosa were
excluded. The experimental design was ap-
proved, from an ethics and scientific stand-
point, by the hospital ethics committee.
Informed consent was obtained.
Anthropometric measurements
The anthropometric and body composi-
tion determinations as well as the blood
extraction were performed on a single day,
as previously described (15,17). BMI was
calculated as weight in kilograms divided
by the square of height in meters. The
Rohrer index was calculated as weight in
kilograms divided by height in meters cu-
bed. Blood pressure was measured as pre-
viously described (15,17).
Body composition
Body density was estimated by ADP (Bod-
Pod, Life Measurements, Concord, CA).
Data for calculation of BF% by this ple-
thysmographicmethod has been reported
to agree closely with the traditional gold
standard of hydrodensitometry underwa-
ter weighing (6). ADP uses the pressure-
volume relationship to estimate volume
and density and has been shown to pre-
dict fat mass and fat-free mass more accu-
rately than DEXA and BIA (6,7). BF% was
estimated from body density using the
Siri equation.
Laboratory procedures
Blood samples were collected after an
overnight fast. Plasma biochemistry was
analyzed as previously described (17–
19). Indirect measures of insulin resis-
tance and insulin sensitivitywere calculated
by using homeostasis model assessment
(HOMA) and quantitative insulin sensitiv-
ity check index (QUICKI), respectively.
Statistical analysis
Data are mean6 SD. A Bland-Altman plot
was used to graphically assess the agree-
ment between BF% determined by ADP
and BF% calculated by the CUN-BAE
(20). HOMA values were logarithmically
transformed because of their non-normal
distribution. Correlations between two
variables were computed by Pearson cor-
relation coefficient. Differences between
correlations were assessed by the two-
tailed Steiger Z test for comparing two de-
pendent correlations within a population.
The accuracy of the predictions was as-
sessed by the SEE. A helpful Excel (Micro-
soft Corp, Redmond, WA) spreadsheet for
the use of the equation can be found in the
SupplementaryData. The calculationswere
performed using SPSS 15.0.1 software
(SPSS, Chicago, IL). A P value , 0.05
was considered statistically significant.
RESULTSdDemographic characteris-
tics of the subjects included in the com-
parison and validation studies are
presented in Supplementary Table 1.
Both cohorts consisted mainly of women
Table 1dCorrelation matrix of BF% with different BAEs and anthropometric variables
Variable All (n = 6,510) Men (n = 2,154) Women (n = 4,356)
BF BMI CUN-BAE BF BMI CUN-BAE BF BMI CUN-BAE
BMI 0.70 d d 0.77 d d 0.84 d d
,0.001 d d ,0.001 d d ,0.001 d d
CUN-BAE 0.89 0.80 d 0.81 0.97 d 0.89 0.94 d
,0.001 ,0.001 d ,0.001 ,0.001 d ,0.001 ,0.001 d
BAI 0.64 0.61 0.68 0.35 0.41 0.40 0.81 0.90 0.86
,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001
Waist-to-height 0.70 0.91 0.75 0.82 0.92 0.94 0.84 0.91 0.91
,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001
Waist-to-height2 0.76 0.85 0.81 0.77 0.85 0.88 0.81 0.87 0.87
,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001
Waist-to-height3 0.75 0.73 0.80 0.69 0.74 0.78 0.75 0.80 0.81
,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001
Weight-to-height 0.60 0.97 0.68 0.74 0.98 0.94 0.82 0.99 0.92
,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001
Rohrer index 0.76 0.96 0.86 0.76 0.98 0.95 0.83 0.98 0.93
,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001
Weight 0.47 0.89 0.54 0.68 0.92 0.87 0.77 0.94 0.88
,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001
Waist 0.57 0.89 0.61 0.81 0.92 0.93 0.82 0.91 0.90
,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001
Hip 0.51 0.65 0.54 0.34 0.41 0.39 0.80 0.91 0.85
,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001
Waist-to-hip ratio 0.15 0.44 0.16 0.49 0.46 0.54 0.47 0.46 0.53
,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001 ,0.001
Data are Pearson correlation coefficients (upper) and associated P values (lower).
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(67–68%). Individuals from the valida-
tion cohort were younger (42.6 6 13.1
vs. 45.1 6 13.1 years; P , 0.001) and
exhibited higher weight (95.2 6 26.1
vs. 86.1 6 22.2 kg; P , 0.001), BMI
(34.9 6 8.7 vs. 31.5 6 7.2 kg/m2; P ,
0.001), and BF% (42.86 10.5 vs. 39.96
10.1; P , 0.001) than subjects from the
comparison cohort. The proportion of
lean overweight and obese subjects in
both cohorts was similar, except for the
proportion of overweight individuals,
which was slightly higher in the valida-
tion cohort (P = 0.003). Therefore, both
cohorts include a wide range of age, BMI,
and BF%, representing a broad spectrum
of the population.
Themean BF% in thewhole sample of
the comparison cohort determined by
ADP was 39.9 6 10.1% (men 34.4 6
8.7%; women 42.7 6 9.6%), whereas
the mean BF% estimated by the CUN-
BAE was 39.3 6 8.9% (men 33.8 6
7.1%; women 42.0 6 8.5%). Both varia-
bles showed a high correlation (whole
sample r = 0.89, SEE = 4.66%; men r =
0.81, SEE = 5.20%; women r = 0.89,
SEE = 4.36%; P, 0.0001 for all; Table 1).
The Bland-Altman method for compari-
son of agreement between BF% measured
by ADP and calculated by the CUN-BAE
prediction equation showed a mean bias
of 20.64 6 9.22% (2 SD, 29.86 6
8.58%; Fig. 1). A total of 6,215 subjects
(95.5%) fell within the 95% CI. Linear re-
gression analysis showed a significant
dependence (P, 0.001) between the dif-
ference of CUN-BAE and ADP and the
mean of both methods being attributable
to the high sample size, which is not con-
sidered clinically relevant (R2 = 0.07).
We next examined which anthropo-
metric measurements best correlated with
BF% measured by ADP. In the whole
group of 6,510 subjects, BF% calculated
with the CUN-BAE showed the highest
correlation with actual BF% (r = 0.89), fol-
lowed by waist-to-height2 ratio and the
Rohrer index (r = 0.76 for both) (Table 1).
In the sample of 2,154 men, waist-to-
height ratio showed the highest correla-
tion (r = 0.82), followed by CUN-BAE
and waist circumference (r = 0.81 for
both). When only women were included
in the analysis (n = 4,356), the CUN-BAE
was the best estimator (r = 0.89), followed
by BMI and waist-to-height ratio (r = 0.84
for both). The correlation of CUN-BAE
with BF% was significantly higher than
that of BMI with BF% for the whole sam-
ple and stratified by sex (P , 0.0001 for
the three comparisons by Steiger Z tests).
The new equation was validated in a
separate cohort of 1,149 individuals. As
can be observed in Fig. 2, BF% estimated
by CUN-BAE showed a higher correlation
with BF% measured by ADP for men (r =
0.85, P , 0.0001, SEE = 5.53%) or
women (r = 0.90, P , 0.0001, SEE =
4.13%) than BMI (men r = 0.83, P ,
0.0001; women r = 0.84, P , 0.0001).
The correlation was also very strong
when the whole sample was analyzed
globally (r = 0.90, P , 0.0001, SEE =
4.62%) The correlations of CUN-BAE
with BF% were again significantly higher
than that of BMI with BF% (P , 0.0001
for the whole sample and women, P =
0.0003 for men). A further advantage of
estimating BF% by CUN-BAE is that the
well-known sex differences in BMI are
dispelled because sex is included in the
equation, as evidenced in Fig. 2B.
To evaluate the degree of association
of BF% estimated with the CUN-BAE
with different cardiometabolic risk factors
and to compare it with BMI and waist
circumference, a bivariate correlation
analysis was done. This study was per-
formed in a subgroup of 634 individuals
where blood pressure, glucose level, lip-
id profile, and several inflammatory/
prothrombotic markers were available for
all of the subjects. In men, body adiposity
estimated with the CUN-BAE was better
correlated with systolic blood pressure
(P = 0.017), logHOMA (P = 0.004),
QUICKI (P = 0.0004), and total choles-
terol (P = 0.0005) than BMI. Moreover,
CUN-BAE was better correlated with
QUICKI (P = 0.029) and marginally
with logHOMA (P = 0.056) than waist
circumference (Table 2). In women, BF
% calculated with the CUN-BAE was bet-
ter correlated with systolic blood pressure
(P = 0.002), triglycerides (P = 0.012), and
total (P , 0.0001) and LDL cholesterol
(P , 0.0001), exhibiting weaker correla-
tion with insulin levels (P = 0.0001) than
BMI. Furthermore, CUN-BAE was better
correlated with logHOMA (P = 0.018),
QUICKI (P = 0.003), total (P = 0.009)
and LDL cholesterol (P = 0.023), and
C-reactive protein (P = 0.001) than waist
circumference (Table 2). Of the 634 sub-
jects of this sample, 224 exhibited a fast-
ing plasma glucose level$100 mg/dL. Of
the 224, 34 individuals had a BMI ,30
kg/m2, with 32 showing a BF% estimated
with the CUN-BAE well within the obe-
sity range (.25% for men and.35% for
women). Therefore, 5% of the subjects
from the sample would benefit from
having a blood test after being diagnosed
Figure 1dBland-Altman plot shows the limits of agreement between BF% estimated using CUN-
BAE and BF% measured by ADP in the comparison sample of 6,510 subjects. The middle red line
represents the mean difference between the estimated and the measured BF%. The dotted lines
indicate 6 2 SDs from the mean.
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as obese according to the CUN-BAE to
discard an impaired glucose tolerance.
CONCLUSIONSdThemain objective
of the current study was to analyze the
accuracy and utility of a new equation
based on BF% measured by ADP and
developed for the prediction of BF%
using BMI, age, and sex (15). We herein
show that CUN-BAE may estimate BF%
with a good accuracy, providing a useful
tool in epidemiologic and clinical stud-
ies without access to specialized body
composition measurements to analyze
adiposity-related cardiometabolic risks.
BMI is frequently used as an indicator
of BF%. However, although it is useful in
epidemiologic studies, it is highly impre-
cise at estimating body fat at an individual
level (9,15). We herein have validated a re-
cently described prediction equation that
can estimate BF% in adults with low error
rate and acceptable accuracy. The BF% cal-
culated with the CUN-BAE correlated bet-
ter with the actual BF% measured by ADP
than any other anthropometric variable or
BF% estimator in a sample of 6,510 indi-
viduals from both sexes with a wide range
of BMI, BF%, and age.
Several prediction equations have
been developed to predict body adiposity.
In general, these prediction models are
derived from small samples and are fre-
quently based on not very precise body
composition techniques, such as skinfolds
or BIA, or are focused on specific age ranges
(10,12–14). To our knowledge, only four
studies have provided prediction equa-
tions developed in samples.1,000 adults
from a wide spectrum of age ranges and
from data obtained with body composition
techniques such as underwater weighing,
DEXA, or four-compartment model
(16,21–23). Our equation was developed
from data obtained from 6,123 subjects
aged 18–80 years and encompassing
BMIs between 12.4 and 72.8 kg/m2 and
BF% between 2.1 and 69.6%. In this
sense, previous equations have some lim-
itations, including having been derived
from individuals with a maximum BMI
of 40.9 kg/m2 (24) and 35.0 kg/m2 (22)
or were obtained from adults aged 30–61
years and with body weights ,110 kg
(23), which may not be representative to
apply to the whole population, affecting
its accuracy.
Very recently, another index for body
adiposity, named BAI, was developed
based on hip circumference data of 1,733
Mexican American adults. In our hands,
this index exhibited a lower correlation
with BF%measured by ADP and amarked
sexual dimorphism, being better corre-
lated inwomen than inmen, with a similar
tendency than that observed for hip cir-
cumference. Although hip circumference
does not seem to be a good estimator of
BF% and is known to be associated with
lower cardiometabolic risk, this novel in-
dexmay be useful inMexican American or
African American populations (16).
One important aspect of our study is
that our equation takes into account the
effect of age. The relation between BMI
and BF%has been shown to be dependent
on age (9). Older adults, irrespective of
sex, have on average more body adiposity
than younger adults at any given BMI (8).
Therefore, prediction equations devel-
oped to estimate BF% only from BMI,
even if they are derived from a sample in-
cluding subjects from all ages, will gener-
ally tend to underestimate the amount of
body fat in the elderly and to overestimate
it in the young (9,11). Including age in the
prediction equation and the interactions
of age with the linear and quadratic BMI
components consistently reduces the er-
ror due to age in the BF% estimations.
Another advantage of CUN-BAE re-
lies on better correlations with cardio-
metabolic risk factors than BMI and even
Figure 2dCorrelation stratified by sex between BF% measured by ADP and BMI (A) and BF% estimated using CUN-BAE (B) in the validation
sample of 1,149 subjects (366 men and 783 women). Pearson correlation coefficients and associated P values are shown for the whole sample and
stratified by sex. Tendency lines are shown for men and women in panel A and for the whole sample in panel B.
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than waist circumference for both men
andwomen in a subset of 634 subjects. To
our knowledge, this is the first study val-
idating a prediction equation for BF%,
going a step further and studying its clin-
ical usefulness analyzing how predicted
BF% might help to explain the changes
observed in these risk factors in relation to
body composition. This aspect is extremely
relevant because BF% has been shown to
better correlate with cardiometabolic risk
factor than BMI (15). Furthermore, be-
cause actual adiposity is a major risk factor
for the development of prediabetes and
type 2 diabetes (17), our equation may
also represent a helpful tool to detect
patients at risk for these conditions.
Our study has several strengths: First,
our prediction equation has been devel-
oped from a large sample of 6,123 subjects
from both sexes with a wide range of body
adiposity, from constitutional thinness to
extreme obesity, and from all adult ages
(18–80 years), and has been validated in
two large cohorts representing all ages and
ponderal groups. Second, actual BF% data
have been measured by a highly precise
technique such as the ADP. This technique
has been shown to predict fat mass more
accurately than DEXA and BIA using hy-
drodensitometry as the reference method
(5–7,25). Third, as mentioned before, BF%
estimated with our equation may be useful
when studying cardiometabolic risk factors.
However, our study has also one po-
tential limitation that pertains to the gen-
eralizability to other populations. The
present work was conducted in white sub-
jects and needs to be extended to other
populations to determine its applicability.
In summary, because the possibility
of measuring BF% is not always available
and the relation between BMI and BF% is
highly dependent on sex and age, we have
developed and validated an easy-to-apply
predictive equation that may be used as a
first screening tool in medical practice.
Furthermore, our equation may be a use-
ful clinical tool for identifying patients
with increased cardiovascular and type 2
diabetes risk.
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